You can buy or sell ABUS and other stocks, options, and ETFs commission-free!
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.
William H. Collier
52 Week High
52 Week Low
Recap: Arbutus Biopharma Q4 Earnings
Shares of Arbutus Biopharma (NASDAQ:ABUS) fell 6.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 50.
-$0.22 per share
-$0.23 per share